Exclusive: U.S. Cardinal Health puts $1.5 billion China business on block – sources

HONG KONG (Reuters) – U.S. drug distributor Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms in a deal that may be worth up to $1.5 billion, sources familiar with the matter said.
( read original story …)


Related Post

Bitfinex and Tether Secure New Banking Partnership...
views 12
Bitfinex and Tether recently announced new banking...
RHB Investment issues new call warrants over HK-li...
views 11
KUALA LUMPUR: RHB Investment Bank Bhd, the investm...
Hong Kong Investor Who Exposed `Enigma NetworkR...
views 11
The list centers around China Huarong and China Mi...
Hong Kong stocks come off lows amid hopes for Chin...
views 12
HONG KONG (Nikkei Markets ... on Friday provided v...
Hong Kong has more millionaires than ever before b...
views 15
Rival finance hub Singapore crept into the top 10,...
Karl Kwok talks business tricks learned from years...
views 20
Karl Kwok has led an illustrious business career t...
Tricor Hong Kong Expands Its Commercial Team and A...
views 19
HONG KONG--(BUSINESS WIRE)--Tricor Group (Tricor),...
Property technology set to rejig real-estate scene
views 21
Experts believe Hong Kong, one of the most mature ...
250 live geckos from Hong Kong seized by Customs a...
views 21
MANILA, Philippines — The Bureau of Customs (BOC) ...
Losses May Accelerate For Hong Kong Stock Market
views 25
Among the actives, China Petroleum and Chemical (S...